Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 516593, 7 pages
http://dx.doi.org/10.1155/2014/516593
Research Article

Anti-hnRNP B1 (RA33) Autoantibodies Are Associated with the Clinical Phenotype in Russian Patients with Rheumatoid Arthritis and Systemic Sclerosis

1Department of Rheumatology, Almazov Medical Research Centre, 197341 St. Petersburg, Russia
2Laboratory of Autoimmune Diagnostics, St. Petersburg Pavlov State Medical University, 197022 St. Petersburg, Russia
3Eichwald Department of Therapy and Rheumatology, Mechnikov Northwestern State University, 191015 St. Petersburg, Russia
4Faculty of Science, Brandenburg University of Technology Cottbus-Senftenberg, Großenhainer Straße 57, 01968 Senftenberg, Germany
5R/D, Medipan GmbH, Dahlewitz, 15827 Berlin, Germany
6Institute of Liver Studies, Division of Transplantation Immunology and Mucosal Biology, King’s College London School of Medicine at King’s College Hospital, London SES 9RJ, UK

Received 14 January 2014; Revised 9 April 2014; Accepted 9 April 2014; Published 4 May 2014

Academic Editor: Michael Mahler

Copyright © 2014 Aleksey Maslyanskiy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Krecic and M. S. Swanson, “hnRNP complexes: composition, structure, and function,” Current Opinion in Cell Biology, vol. 11, no. 3, pp. 363–371, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. W. J. van Venrooij and G. J. M. Pruijn, “Ribonucleoprotein complexes as autoantigens,” Current Opinion in Immunology, vol. 7, no. 6, pp. 819–824, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Caporali, S. Bugatti, E. Bruschi, L. Cavagna, and C. Montecucco, “Autoantibodies to heterogeneous nuclear ribonucleoproteins,” Autoimmunity, vol. 38, no. 1, pp. 25–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Hassfeld, G. Steiner, K. Hartmuth et al., “Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis,” Arthritis and Rheumatism, vol. 32, no. 12, pp. 1515–1520, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Steiner, K. Skriner, and J. S. Smolen, “Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases,” International Archives of Allergy and Immunology, vol. 111, no. 4, pp. 314–319, 1996. View at Google Scholar · View at Scopus
  6. D. A. Isenberg, G. Steiner, and J. S. Smolen, “Clinical utility and serological connections of anti-RA33 antibodies in systemic lupus erythematosus,” Journal of Rheumatology, vol. 21, no. 7, pp. 1260–1263, 1994. View at Google Scholar · View at Scopus
  7. W. Hassfeld, G. Steiner, A. Studnicka-Benke et al., “Autoimmune response to the spliceosome: an immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 38, no. 6, pp. 777–785, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Conrad, D. Roggenbuck, D. Reinhold, and T. Dörner, “Profiling of rheumatoid arthritis associated autoantibodies,” Autoimmunity Reviews, vol. 9, no. 6, pp. 431–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Hassfeld, G. Steiner, W. Graininger, G. Witzmann, H. Schweitzer, and J. S. Smolen, “Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis,” British Journal of Rheumatology, vol. 32, no. 3, pp. 199–203, 1993. View at Google Scholar · View at Scopus
  10. K. Op de Beéck, L. Maes, K. Van Den Bergh et al., “Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases,” Arthritis and Rheumatism, vol. 64, no. 1, pp. 213–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Zöphel, G. Wunderlich, J. Kotzerke, P. von Landenberg, and D. Roggenbuck, “M22 based (manual) ELISA for TSH-receptor antibody (TRAb) measurement is more sensitive than 2nd generation TRAb assays,” Clinica Chimica Acta, vol. 403, no. 1-2, p. 266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Siapka, M. Patrinou-Georgoula, P. G. Vlachoyiannopoulos, and A. Guialis, “Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen,” Autoimmunity, vol. 40, no. 3, pp. 223–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Nell-Duxneuner, K. Machold, T. Stamm et al., “Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 169–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. V. P. Nell, K. P. Machold, T. A. Stamm et al., “Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 12, pp. 1731–1736, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Conrad, H. Schneider, T. Ziemssen et al., “A new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies,” Annals of the New York Academy of Sciences, vol. 1109, pp. 256–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Conrad, D. Roggenbuck, D. Reinhold, and U. Sack, “Autoantibody diagnostics in clinical practice,” Autoimmunity Reviews, vol. 11, no. 3, pp. 207–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Willitzki, R. Hiemann, V. Peters et al., “New platform technology for comprehensive serological diagnostics of autoimmune diseases,” Clinical and Developmental Immunology, vol. 2012, Article ID 284740, 8 pages, 2012. View at Publisher · View at Google Scholar
  18. D. Roggenbuck, K. Egerer, P. von Landenberg et al., “Antiphospholipid antibody profiling-time for a new technical approach?” Autoimmunity Reviews, vol. 11, no. 11, pp. 821–826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Egerer, D. Roggenbuck, T. Büttner et al., “Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay,” Arthritis Research and Therapy, vol. 13, no. 4, p. R118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Zimmermann, G. Steiner, K. Skriner, W. Hassfeld, P. Petera, and J. S. Smolen, “The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome,” Arthritis & Rheumatology, vol. 41, no. 11, pp. 1938–1945, 1998. View at Google Scholar
  21. T. Horiki, J. Moriuchi, M. Takaya et al., “The coexistence of systemic sclerosis and rheumatoid arthritis in five patients: clinical and immunogenetic features suggest a distinct entity,” Arthritis and Rheumatism, vol. 39, no. 1, pp. 152–156, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Generini, G. Steiner, I. Miniati et al., “Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement,” Rheumatology, vol. 48, no. 8, pp. 920–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Avouac, H. Guerini, J. Wipff et al., “Radiological hand involvement in systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 65, no. 8, pp. 1088–1092, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Skriner, W. H. Sommergruber, V. Tremmel et al., “Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex: differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease,” Journal of Clinical Investigation, vol. 100, no. 1, pp. 127–135, 1997. View at Google Scholar · View at Scopus
  25. D. Roggenbuck, D. Reinhold, P. Schierack, D. P. Bogdanos, K. Conrad, and M. W. Laass, “Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 4, pp. 483–494, 2014. View at Google Scholar
  26. O. Derganova, L. Martinez-Gamboa, K. Egerer et al., “Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV)are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients,” Clinical Experimental Rheumatology, 2014, in press.
  27. J. S. Smolen and G. Steiner, “Are autoantibodies active players or epiphenomena?” Current Opinion in Rheumatology, vol. 10, no. 3, pp. 201–206, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Laurent, J. Cockcroft, L. Van Bortel et al., “Expert consensus document on arterial stiffness: methodological issues and clinical applications,” European Heart Journal, vol. 27, no. 21, pp. 2588–2605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Constans, C. Germain, P. Gosse et al., “Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study,” Journal of Hypertension, vol. 25, no. 9, pp. 1900–1906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Timár, P. Soltész, S. Szamosi et al., “Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis,” Journal of Rheumatology, vol. 35, no. 7, pp. 1329–1333, 2008. View at Google Scholar · View at Scopus